CN111995605B - Chrysin cinnamate or its derivative and its preparation method - Google Patents
Chrysin cinnamate or its derivative and its preparation method Download PDFInfo
- Publication number
- CN111995605B CN111995605B CN202010891873.1A CN202010891873A CN111995605B CN 111995605 B CN111995605 B CN 111995605B CN 202010891873 A CN202010891873 A CN 202010891873A CN 111995605 B CN111995605 B CN 111995605B
- Authority
- CN
- China
- Prior art keywords
- chrysin
- structural formula
- reaction
- preparation
- cinnamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RTIXKCRFFJGDFG-UHFFFAOYSA-N chrysin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 title claims abstract description 102
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 229940043370 chrysin Drugs 0.000 title claims abstract description 51
- 235000015838 chrysin Nutrition 0.000 title claims abstract description 51
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 229940114081 cinnamate Drugs 0.000 title claims abstract description 17
- 239000003054 catalyst Substances 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 238000005741 Steglich esterification reaction Methods 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 60
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 56
- 150000001875 compounds Chemical class 0.000 claims description 55
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical group CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 50
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 40
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 239000003208 petroleum Substances 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 18
- 230000035484 reaction time Effects 0.000 claims description 5
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 abstract description 28
- 229930016911 cinnamic acid Natural products 0.000 abstract description 28
- 235000013985 cinnamic acid Nutrition 0.000 abstract description 28
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 abstract description 28
- 238000000034 method Methods 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 23
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 21
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 21
- 238000001514 detection method Methods 0.000 description 17
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 9
- 230000004071 biological effect Effects 0.000 description 8
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 150000007930 O-acyl isoureas Chemical class 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QMGHHBHPDDAGGO-IIWOMYBWSA-N (2S,4R)-1-[(2S)-2-[[2-[3-[4-[3-[4-[[5-bromo-4-[3-[cyclobutanecarbonyl(methyl)amino]propylamino]pyrimidin-2-yl]amino]phenoxy]propoxy]butoxy]propoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide Chemical compound CN(CCCNC1=NC(NC2=CC=C(OCCCOCCCCOCCCOCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCC3=CC=C(C=C3)C3=C(C)N=CS3)C(C)(C)C)C=C2)=NC=C1Br)C(=O)C1CCC1 QMGHHBHPDDAGGO-IIWOMYBWSA-N 0.000 description 2
- IZGDXVLRMHXOJV-SFHVURJKSA-N (3s)-4-[2-[2-(4-fluoro-3-methylphenyl)-4-methyl-6-propan-2-ylphenyl]ethyl-hydroxyphosphoryl]-3-hydroxybutanoic acid Chemical compound CC(C)C1=CC(C)=CC(C=2C=C(C)C(F)=CC=2)=C1CCP(O)(=O)C[C@@H](O)CC(O)=O IZGDXVLRMHXOJV-SFHVURJKSA-N 0.000 description 2
- WHQUHTXULUACFD-KRWDZBQOSA-N (3s)-4-[[2-(4-fluoro-3-methylphenyl)-4-methyl-6-propan-2-ylphenyl]methoxy-hydroxyphosphoryl]-3-hydroxybutanoic acid Chemical compound CC(C)C1=CC(C)=CC(C=2C=C(C)C(F)=CC=2)=C1COP(O)(=O)C[C@@H](O)CC(O)=O WHQUHTXULUACFD-KRWDZBQOSA-N 0.000 description 2
- MNIPVWXWSPXERA-IDNZQHFXSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-(11-phenoxyundecanoyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@@H]([C@@H](OC(=O)CCCCCCCCCCOC=3C=CC=CC=3)C(O1)(C(O)=O)C(O)(C(O2)C(O)=O)C(O)=O)O)C1=CC=CC=C1 MNIPVWXWSPXERA-IDNZQHFXSA-N 0.000 description 2
- BOOYHBPHFVNWNH-OAHLLOKOSA-N 1-tert-butyl-6-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-5-[(4-fluorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-one Chemical compound C[C@H](C1=CC=C(C=C1)Cl)NC2=NC3=C(C=NN3C(C)(C)C)C(=O)N2CC4=CC=C(C=C4)F BOOYHBPHFVNWNH-OAHLLOKOSA-N 0.000 description 2
- PSWDQTMAUUQILQ-UHFFFAOYSA-N 2-[(6-methoxy-4-methylquinazolin-2-yl)amino]-5,6-dimethyl-1h-pyrimidin-4-one Chemical compound N1=C(C)C2=CC(OC)=CC=C2N=C1NC1=NC(=O)C(C)=C(C)N1 PSWDQTMAUUQILQ-UHFFFAOYSA-N 0.000 description 2
- 229940126650 Compound 3f Drugs 0.000 description 2
- KGPGFQWBCSZGEL-ZDUSSCGKSA-N GSK690693 Chemical compound C=12N(CC)C(C=3C(=NON=3)N)=NC2=C(C#CC(C)(C)O)N=CC=1OC[C@H]1CCCNC1 KGPGFQWBCSZGEL-ZDUSSCGKSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 2
- 229940125796 compound 3d Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- MUTCAPXLKRYEPR-ITWZMISCSA-N methyl (e,3r,5s)-7-[4-bromo-2,3-bis(4-fluorophenyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyhept-6-enoate Chemical compound COC(=O)C[C@H](O)C[C@H](O)\C=C\N1C(C(C)C)=C(Br)C(C=2C=CC(F)=CC=2)=C1C1=CC=C(F)C=C1 MUTCAPXLKRYEPR-ITWZMISCSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
- MYQKIWCVEPUPIL-QFIPXVFZSA-N 7-ethylcamptothecin Chemical compound C1=CC=C2C(CC)=C(CN3C(C4=C([C@@](C(=O)OC4)(O)CC)C=C33)=O)C3=NC2=C1 MYQKIWCVEPUPIL-QFIPXVFZSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940017545 cinnamon bark Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于有机合成领域,具体涉及一种白杨素肉桂酸酯或其衍生物及其制备方法。The invention belongs to the field of organic synthesis, and in particular relates to a chrysin cinnamate or a derivative thereof and a preparation method thereof.
背景技术Background technique
将具有生物活性的两个或者多个分子,通过反应合成具有潜在生物活性的新分子,是一种构造新化合物的重要策略[1-2]。白杨素是一种从紫威科植物木蝴蝶中提取的具有广泛药理活性的天然多酚类黄酮化合物[3],其广泛存在于蜂蜜与蜂蜡之中,具有抗氧化、抗病毒、降血糖、抗焦虑等多种生物活性[4-8],但其也存在着溶解性低,生物利用度较差等缺点[8-9]。肉桂酸是一种从传统中药肉桂皮中提取的化合物[10],与其衍生物在自然界中广泛存在,具有抗氧化、抗肿瘤、抑菌等多种生物活性[11-14],研究发现,多种肉桂酸类衍生物的生物活性高于其原型药物[15]。因此,通过将白杨素和肉桂酸衍生物反应合成一系列具有多样性特征的新化合物,将为生物活性筛选提供化合物源。It is an important strategy to construct new compounds by reacting two or more molecules with biological activity to synthesize new molecules with potential biological activity [1-2] . Chrysin is a natural polyphenolic flavonoid compound with a wide range of pharmacological activities, which is extracted from the Violaceae plant Arborinae [3] . It is widely found in honey and beeswax, and has antioxidant, antiviral, hypoglycemic, Anti-anxiety and other biological activities [4-8] , but it also has disadvantages such as low solubility and poor bioavailability [8-9] . Cinnamic acid is a compound extracted from traditional Chinese medicine cinnamon bark [10] , and its derivatives are widely found in nature, and have various biological activities such as anti-oxidation, anti-tumor, and antibacterial [11-14] . Studies have found that, The biological activities of various cinnamic acid derivatives are higher than those of their prototype drugs [15] . Therefore, by reacting chrysin and cinnamic acid derivatives to synthesize a series of new compounds with diverse characteristics, it will provide a source of compounds for biological activity screening.
发明内容Contents of the invention
为解决上述现有技术中存在的缺点和不足,本发明的目的在于提供一种白杨素肉桂酸酯或其衍生物及其制备方法。In order to solve the shortcomings and deficiencies in the above-mentioned prior art, the object of the present invention is to provide a kind of chrysin cinnamate or derivatives thereof and a preparation method thereof.
为了达到上述目的,第一方面,本发明提供了一种白杨素肉桂酸酯或其衍生物的制备方法,其包括以下步骤:将白杨素(结构如式(1)所示)和结构式(2)所示的化合物在缩合剂和催化剂作用下于有机溶剂中发生Steglich酯化反应,即得所述白杨素肉桂酸酯或其衍生物,所述白杨素肉桂酸酯或其衍生物的结构式如式(3)所示;In order to achieve the above object, the first aspect, the present invention provides a kind of preparation method of chrysin cinnamate or derivative thereof, it comprises the following steps: combine chrysin (structure as shown in formula (1)) and structural formula (2 ) under the action of a condensing agent and a catalyst to undergo a Steglich esterification reaction in an organic solvent to obtain the chrysin cinnamate or a derivative thereof, and the structural formula of the chrysin cinnamate or a derivative thereof is as Shown in formula (3);
各R独立地为卤素、硝基、直链或支链烷基、或直链或支链烷氧基,或者两个相邻R连接在一起形成-O(CH2)pO-;n为0~5的整数;p为1以上的整数。Each R is independently halogen, nitro, straight-chain or branched-chain alkyl, or straight-chain or branched-chain alkoxy, or two adjacent Rs are linked together to form -O(CH 2 ) p O-; n is An integer of 0 to 5; p is an integer of 1 or more.
上述制备方法通过一步法即制得白杨素肉桂酸酯或其衍生物,不仅方法简单,易于工业化生产,目标产物产率高,在40%以上,而且所得白杨素肉桂酸酯或其衍生物具有白杨素以及肉桂酸或其衍生物的特性,为生物活性筛选提供了化合物源。The above-mentioned preparation method can obtain chrysin cinnamate or its derivatives through a one-step method. Not only is the method simple, it is easy for industrial production, and the yield of the target product is high, above 40%, and the obtained chrysin cinnamate or its derivatives have The characteristics of chrysin and cinnamic acid or its derivatives provide a source of compounds for biological activity screening.
作为本发明制备方法的优选实施方式,所述n为0、1或2。As a preferred embodiment of the preparation method of the present invention, the n is 0, 1 or 2.
作为本发明制备方法的优选实施方式,所述n为1,所述R为2-CH3-、3-CH3-、4-CH3-、2-Cl、3-Cl、4-Cl、2-Br、3-Br、4-Br、2-F、3-F、4-F、2-NO2-、3-NO2-、4-NO2-、2-OCH3、3-OCH3或4-OCH3;或者所述n为2,两个R相同且分别为卤素、硝基、直链或支链烷基、或直链或支链烷氧基,或者两个R相邻并连接在一起形成-O-(CH2)p-O-。As a preferred embodiment of the preparation method of the present invention, said n is 1, and said R is 2-CH 3 -, 3-CH 3 -, 4-CH 3 -, 2-Cl, 3-Cl, 4-Cl, 2-Br, 3-Br, 4-Br, 2-F, 3-F, 4-F, 2-NO 2 -, 3-NO 2 -, 4-NO 2 -, 2-OCH 3 , 3-OCH 3 or 4-OCH 3 ; or the n is 2, and the two Rs are the same and are respectively halogen, nitro, straight-chain or branched-chain alkyl, or straight-chain or branched-chain alkoxy, or two Rs are adjacent and link together to form -O-(CH 2 ) p -O-.
作为本发明制备方法的优选实施方式,所述n为2,两个R相同且分别为3-OCH3和4-OCH3,或者两个R相邻并连接在一起形成3,4(O-CH2-O)。As a preferred embodiment of the preparation method of the present invention, the n is 2, the two Rs are the same and are respectively 3-OCH 3 and 4-OCH 3 , or the two Rs are adjacent and connected together to form 3,4(O- CH2 -O).
作为本发明制备方法的优选实施方式,所述缩合剂为1-乙基-3(3-二甲基丙胺)碳二亚胺(即EDCI),所述催化剂为4-二甲氨基吡啶(即DMAP)。以EDCI作为缩合剂,DMAP作为催化剂时,所得目标产物不但收率高,而且更易纯化。As a preferred embodiment of the preparation method of the present invention, the condensing agent is 1-ethyl-3 (3-dimethylpropylamine) carbodiimide (ie EDCI), and the catalyst is 4-dimethylaminopyridine (ie DMAP). When EDCI is used as the condensation agent and DMAP is used as the catalyst, the target product not only has a high yield, but is also easier to purify.
作为本发明制备方法的优选实施方式,所述Steglich酯化反应的反应温度为0-45℃,反应时间为4-24h,所述白杨素、所述结构式(2)所示的化合物、所述缩合剂和所述催化剂的摩尔比为白杨素:结构式(2)所示的化合物:缩合剂:催化剂=1:1.5:1.5:0.5。As a preferred embodiment of the preparation method of the present invention, the reaction temperature of the Steglich esterification reaction is 0-45°C, the reaction time is 4-24h, the chrysin, the compound represented by the structural formula (2), the The molar ratio of the condensing agent and the catalyst is chrysin:compound represented by structural formula (2):condensing agent:catalyst=1:1.5:1.5:0.5.
作为本发明制备方法的优选实施方式,所述Steglich酯化反应的反应温度为常温,反应时间为6h,所述白杨素、所述结构式(2)所示的化合物、所述缩合剂和所述催化剂的摩尔比为白杨素:结构式(2)所示的化合物:缩合剂:催化剂=1:1.5:1.5:0.5。As a preferred embodiment of the preparation method of the present invention, the reaction temperature of the Steglich esterification reaction is normal temperature, the reaction time is 6h, the chrysin, the compound shown in the structural formula (2), the condensing agent and the The molar ratio of the catalyst is chrysin: compound shown in structural formula (2): condensing agent: catalyst = 1:1.5:1.5:0.5.
作为本发明制备方法的优选实施方式,所述Steglich酯化反应在保护气保护下进行。As a preferred embodiment of the preparation method of the present invention, the Steglich esterification reaction is carried out under the protection of protective gas.
作为本发明制备方法的优选实施方式,所述制备方法还包括以下步骤:将所述Steglich酯化反应后的体系固液分离,收集固体并依次使用石油醚、乙酸乙酯和丙酮洗涤。依次经石油醚、乙酸乙酯和丙酮洗涤后,即可除去杂质,获得纯净的目标产物,纯化方法非常简单。As a preferred embodiment of the preparation method of the present invention, the preparation method further includes the following steps: separating the solid from the liquid of the Steglich esterification system, collecting the solid and washing it with petroleum ether, ethyl acetate and acetone in sequence. After washing with petroleum ether, ethyl acetate and acetone in sequence, the impurities can be removed and the pure target product can be obtained. The purification method is very simple.
作为本发明制备方法的优选实施方式,所述制备方法还包括以下步骤:在所述洗涤后,进行干燥处理。As a preferred embodiment of the preparation method of the present invention, the preparation method further includes the following step: performing drying treatment after the washing.
第二方面,本发明提供了上述制备方法制得的白杨素肉桂酸酯或其衍生物。In the second aspect, the present invention provides chrysin cinnamate or derivatives thereof prepared by the above preparation method.
与现有技术相比,本发明具有如下优点:本发明将白杨素和肉桂酸或其衍生物通过一步法制得白杨素肉桂酸酯或其衍生物,不仅方法简单,易于工业化生产,目标产物产率高,在40%以上,而且所得白杨素肉桂酸酯或其衍生物具有白杨素以及肉桂酸或其衍生物的特性,为生物活性筛选提供了化合物源。Compared with the prior art, the present invention has the following advantages: in the present invention, chrysin cinnamate or its derivatives are prepared by one-step process of chrysin and cinnamic acid or its derivatives. The yield is high, above 40%, and the obtained chrysin cinnamate or its derivatives have the characteristics of chrysin and cinnamic acid or its derivatives, providing a compound source for biological activity screening.
附图说明Description of drawings
图1为各实施例的反应路线图(原料2a与产物3a对应,原料2b与产物3c对应……依次类推,原料2n与产物3n对应);Fig. 1 is the reaction route diagram of each embodiment (raw material 2a corresponds to
图2为本发明白杨素和肉桂酸的反应机理。Fig. 2 is the reaction mechanism of chrysin and cinnamic acid of the present invention.
具体实施方式Detailed ways
为更好的说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步说明。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific examples.
下述各实施例所采用的试剂均为分析纯,所用仪器分别为OptiMelt MPA100型熔点测定仪(美国SRS公司);Bruker 500MHz型核磁共振仪(德国BRUKER公司,DMSO-d6为溶剂,TMS为内标);Thermo Fishor LCQ Fleet型液相色谱-质谱联用仪(美国Thermo FisherSeientific公司)。The reagents adopted in each of the following embodiments are analytically pure, and the instruments used are respectively OptiMelt MPA100 type melting point analyzer (SRS company of the U.S.); standard); Thermo Fisher LCQ Fleet liquid chromatography-mass spectrometry (Thermo Fisher Seientific, USA).
实施例1Example 1
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2a)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3a(白杨素肉桂酸酯)。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2a)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and then dried to obtain
所得化合物3a:黄色固体,收率95.1%,m.p.(即熔点)211.4~213.2℃;1H NMR(500MHz,DMSO-d6)δ:12.87(s,1H),8.14(d,J=7.4Hz,2H),7.95~7.82(m,2H),7.80(d,J=8.8Hz,1H),7.63(dq,J=14.7,7.1Hz,3H),7.51~7.45(m,1H),7.22(dd,J=11.2,2.1Hz,1H),7.18(d,J=2.6Hz,1H),7.02(s,1H),6.93(d,J=16.1Hz,1H),6.81~6.73(m,2H);13CNMR(125MHz,DMSO-d6)δ:182.15,170.25,164.80,161.28,159.04,156.98,138.96,136.43,133.26,132.96,131.27,129.73,129.30,127.16,117.12,115.01,108.73,106.25,105.96,102.27;LC-MS(ESI)m/z:C24H16KO5{[M+K]+}计算值423.06,实际值423.18。Obtained
实施例2Example 2
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2b)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3b。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2b)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3b:淡黄色固体,收率82.4%,m.p.167.2~169.1℃;1H NMR(500MHz,DMSO-d6)δ:12.89(s,1H),8.15(d,J=7.1Hz,2H),8.11(d,J=15.9Hz,1H),7.87(d,J=7.9Hz,1H),7.63(dt,J=14.6,7.0Hz,3H),7.42~7.35(m,1H),7.34~7.27(m,2H),7.24(d,J=2.0Hz,1H),7.19(s,1H),6.83(d,J=15.9Hz,1H),6.80(d,J=2.0Hz,1H),2.46(s,3H);13C NMR(125MHz,DMSO-d6)δ:183.15,164.71,164.61,161.29,156.85,156.39,144.92,138.45,132.94,132.79,131.39,130.88,129.71,127.43,127.15,127.07,117.95,108.81,106.27,105.94,102.25,19.79;LC-MS(ESI)m/z:C25H19O5{[M+H]+}计算值399.12,实际值399.04。
实施例3Example 3
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2c)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3c。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2c)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3c:淡黄色固体,收率47.8%,m.p.182.1~183.6℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.15(d,J=7.3Hz,2H),7.88(d,J=16.0Hz,1H),7.63(td,J=14.6,7.1Hz,5H),7.37(t,J=7.6Hz,1H),7.31(d,J=7.6Hz,1H),7.23(d,J=2.0Hz,1H),7.19(s,1H),6.90(d,J=16.0Hz,1H),6.78(d,J=2.1Hz,1H),2.36(s,3H);13C NMR(125MHz,DMSO-d6)δ:183.14,164.71,164.64,161.28,156.84,156.42,147.99,138.82,134.13,132.94,132.34,130.87,129.74,129.71,129.42,127.15,126.55,116.85,108.79,106.26,105.93,102.25,21.32;LC-MS(ESI)m/z:C25H18NaO5{[M+Na]+}421.10,实际值421.11。The obtained
实施例4Example 4
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2d)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3d。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2d)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3d:黄色固体,收率57.1%,m.p.190.2~192.5℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.14(d,J=7.1Hz,2H),7.89(d,J=16.0Hz,1H),7.73(d,J=8.1Hz,2H),7.62(dt,J=14.6,7.0Hz,3H),7.29(d,J=7.8Hz,2H),7.22(d,J=2.1Hz,1H),7.19(s,1H),6.86(d,J=16.0Hz,1H),6.78(d,J=2.0Hz,1H),2.36(s,3H);13C NMR(125MHz,DMSO-d6)δ:183.14,164.74,164.70,161.28,156.84,156.47,147.88,141.80,132.93,131.52,130.88,130.16,129.70,129.34,127.15,115.90,108.77,106.26,105.96,102.26,21.60;LC-MS(ESI)m/z:C25H18NaO5{[M+Na]+}计算值421.10,实际值421.09。The obtained
实施例5Example 5
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2e)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3e。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2e)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3e:淡黄色固体,收率77.7%,m.p.197.2~199.8℃;;1H NMR(500MHz,DMSO-d6)δ:2.89(s,1H),8.18–8.12(m,3H),8.11(dd,J=7.9,1.5Hz,1H),7.69–7.58(m,4H),7.52(td,J=7.7,1.7Hz,1H),7.50–7.43(m,1H),7.25(d,J=2.0Hz,1H),7.19(s,1H),7.04(d,J=16.0Hz,1H),6.81(d,J=2.0Hz,1H);13C NMR(125MHz,DMSO-d6)δ:183.16,164.74,164.30,161.32,156.86,156.24,142.15,134.58,133.07,132.95,131.73,130.88,130.63,129.72,129.16,128.43,127.16,120.25,108.90,106.29,105.94,102.27;LC-MS(ESI)m/z:C24H15ClNaO5{[M+Na]+}计算值441.05,实际值441.04。The obtained
实施例6Example 6
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2f)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3f。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2f)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3f:黄色固体,收率55.2%,m.p.202.3~204.5℃;1H NMR(500MHz,DMSO-d6)δ:12.89(s,1H),8.14(d,J=7.1Hz,2H),7.98(s,1H),7.91(d,J=16.1Hz,1H),7.82(d,J=7.6Hz,1H),7.69~7.57(m,3H),7.57~7.53(m,1H),7.50(t,J=7.8Hz,1H),7.23(d,J=2.1Hz,1H),7.18(s,1H),7.03(d,J=16.0Hz,1H),6.79(d,J=2.1Hz,1H);13CNMR(125MHz,DMSO-d6)δ:183.14,164.74,164.42,161.30,156.85,156.32,146.15,136.44,134.33,132.95,131.32,131.15,130.87,129.71,128.84,127.89,127.16,118.86,108.85,106.27,105.92,102.25;LC-MS(ESI)m/z:C24H15ClKO5{[M+K]+}计算值457.02,实际值457.14。Obtained
实施例7Example 7
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2g)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3g。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2g)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3g:淡黄色固体,收率88.7%,m.p.234.6~237.2℃;1H NMR(500MHz,DMSO-d6)δ:12.90(s,1H),8.15(d,J=7.2Hz,2H),7.97–7.87(m,3H),7.64(dq,J=14.6,7.1Hz,3H),7.56(d,J=8.6Hz,2H),7.23(d,J=2.1Hz,1H),7.20(s,1H),6.98(d,J=16.0Hz,1H),6.79(d,J=2.1Hz,1H);LC-MS(ESI)m/z:C24H16ClO5{[M+H]+}计算值419.06,实际值419.07。The obtained
实施例8Example 8
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2h)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3h。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2h)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3h:黄色固体,收率85.5%,m.p.225.2~227.6℃;1H NMR(500MHz,DMSO-d6)δ:12.89(s,1H),8.15(d,J=7.1Hz,2H),7.91(d,J=16.0Hz,1H),7.82(d,J=8.5Hz,2H),7.68(d,J=8.5Hz,2H),7.62(dt,J=14.6,7.0Hz,3H),7.23(d,J=2.1Hz,1H),7.19(s,1H),6.98(d,J=16.1Hz,1H),6.79(d,J=2.0Hz,1H);13C NMR(125MHz,DMSO-d6)δ:183.15,164.73,164.51,161.30,156.85,156.36,146.49,133.53,132.95,132.53,131.22,130.88,129.71,127.16,125.09,118.01,108.84,106.28,105.93,102.25;LC-MS(ESI)m/z:C24H15BrKO5{[M+K]+}计算值500.97,实际值501.05。The obtained
实施例9Example 9
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2i)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3i。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2i)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain compound 3i.
所得化合物3i:淡黄色固体,收率43.4%,m.p.184.7~186.3℃;1H NMR(500MHz,DMSO-d6)δ:12.89(s,1H),8.15(d,J=7.2Hz,2H),7.93(d,J=16.0Hz,1H),7.79(dt,J=10.1,2.1Hz,1H),7.72~7.58(m,4H),7.56~7.48(m,1H),7.33(td,J=8.6,2.3Hz,1H),7.24(d,J=2.0Hz,1H),7.20(s,1H),7.03(d,J=16.1Hz,1H),6.80(d,J=2.1Hz,1H);13CNMR(125MHz,DMSO-d6)δ:183.15,164.73,164.45,161.31,156.86,156.32,146.39,136.76,132.94,131.55,131.48,130.88,129.71,127.16,125.85,118.77,115.46,115.28,108.86,106.29,105.94,102.26;LC-MS(ESI)m/z:C24H15FNaO5{[M+Na]+}计算值425.07,实际值425.08。The obtained compound 3i: pale yellow solid, yield 43.4%, mp184.7~186.3℃; 1 H NMR (500MHz, DMSO-d 6 )δ: 12.89(s, 1H), 8.15(d, J=7.2Hz, 2H ),7.93(d,J=16.0Hz,1H),7.79(dt,J=10.1,2.1Hz,1H),7.72~7.58(m,4H),7.56~7.48(m,1H),7.33(td, J=8.6,2.3Hz,1H),7.24(d,J=2.0Hz,1H),7.20(s,1H),7.03(d,J=16.1Hz,1H),6.80(d,J=2.1Hz, 1H); 13 CNMR (125MHz, DMSO-d 6 ) δ: 183.15, 164.73, 164.45, 161.31, 156.86, 156.32, 146.39, 136.76, 132.94, 131.55, 131.48, 130.88, 129.71, 117.187, 12 6,115.28 , 108.86, 106.29, 105.94, 102.26; LC-MS (ESI) m/z: Calcd. for C 24 H 15 FNaO 5 {[M+Na] + } 425.07, Actual 425.08.
实施例10Example 10
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2j)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3j。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2j)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain
所得化合物3j:黄色固体,收率72.5%,m.p.247.7~251.1℃;1H NMR(500MHz,DMSO-d6)δ:12.90(s,1H),8.30(d,J=8.8Hz,2H),8.19~8.09(m,4H),8.05(d,J=16.0Hz,1H),7.69~7.58(m,3H),7.25(d,J=2.1Hz,1H),7.19(d,J=7.8Hz,1H),7.15(s,1H),6.82(d,J=2.0Hz,1H);13C NMR(125MHz,DMSO-d6)δ:183.19,164.75,164.14,161.33,156.86,156.22,148.91,145.02,140.55,132.96,130.87,130.37,129.72,127.16,124.53,121.50,108.92,106.31,105.91,102.24;LC-MS(ESI)m/z:C24H15NKO7{[M+K]+}计算值468.05,实际值468.20。
实施例11Example 11
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2k)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3k。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2k)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain compound 3k.
所得化合物3k:淡黄色固体,收率89.9%,m.p.169.2~172.5℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.15(d,J=7.1Hz,2H),8.10(d,J=16.1Hz,1H),7.84(dd,J=7.8,1.7Hz,1H),7.69~7.58(m,3H),7.49(td,J=8.1,7.6,1.6Hz,1H),7.22(d,J=2.1Hz,1H),7.19(s,1H),7.16(d,J=8.2Hz,1H),7.05(t,J=7.5Hz,1H),6.91(d,J=16.1Hz,1H),6.78(d,J=2.1Hz,1H),3.91(s,3H);13C NMR(125MHz,DMSO-d6)δ:183.15,164.96,164.70,161.28,158.74,156.85,156.48,142.57,132.94,129.82,129.71,127.16,122.33,121.33,117.06,112.41,106.26,105.99,102.29,56.25;LC-MS(ESI)m/z:C25H18KO6{[M+K]+}计算值453.07,实际值453.19。The obtained compound 3k: pale yellow solid, yield 89.9%, mp169.2~172.5℃; 1 H NMR (500MHz, DMSO-d 6 )δ: 12.88(s, 1H), 8.15(d, J=7.1Hz, 2H ), 8.10(d, J=16.1Hz, 1H), 7.84(dd, J=7.8, 1.7Hz, 1H), 7.69~7.58(m, 3H), 7.49(td, J=8.1, 7.6, 1.6Hz, 1H), 7.22(d, J=2.1Hz, 1H), 7.19(s, 1H), 7.16(d, J=8.2Hz, 1H), 7.05(t, J=7.5Hz, 1H), 6.91(d, J=16.1Hz, 1H), 6.78(d, J=2.1Hz, 1H), 3.91(s, 3H); 13 C NMR (125MHz, DMSO-d 6 ) δ: 183.15, 164.96, 164.70, 161.28, 158.74, 156.85,156.48,142.57,132.94,129.82,129.71,127.16,122.33,121.33,117.06,112.41,106.26,105.99,102.29,56.25 ; LC-MS (ESI) m/z: C 25 H 18 KO K] + } calculated value 453.07, actual value 453.19.
实施例12Example 12
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2l)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3l。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2l)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain compound 3l.
所得化合物3l:黄色固体,收率73.4%,m.p.218.5~221.1℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.17~8.13(m,2H),7.88(d,J=15.9Hz,1H),7.81(d,J=8.8Hz,2H),7.67~7.59(m,3H),7.21(d,J=2.0Hz,1H),7.19(s,1H),7.03(d,J=8.7Hz,2H),6.81~6.75(m,2H),3.82(s,3H),3.83(s,3H);13C NMR(125MHz,DMSO-d6)δ:183.09,164.89,164.69,161.26,157.84,156.84,156.53,147.76,132.94,131.27,130.89,129.71,127.15,115.00,114.14,108.73,106.25,105.96,102.27,55.90;LC-MS(ESI)m/z:C25H19O6{[M+H]+}计算值415.17,实际值415.10。Obtained compound 3l: yellow solid, yield 73.4%, mp218.5~221.1℃; 1 H NMR (500MHz, DMSO-d 6 )δ: 12.88(s, 1H), 8.17~8.13(m, 2H), 7.88( d, J=15.9Hz, 1H), 7.81(d, J=8.8Hz, 2H), 7.67~7.59(m, 3H), 7.21(d, J=2.0Hz, 1H), 7.19(s, 1H), 7.03(d, J=8.7Hz, 2H), 6.81~6.75(m, 2H), 3.82(s, 3H), 3.83(s, 3H); 13 C NMR(125MHz, DMSO-d 6 )δ: 183.09, 164.89, 164.69, 161.26, 157.84, 156.84, 156.53, 147.76, 132.94, 131.27, 130.89, 129.71, 127.15, 115.00, 114.14, 108.73, 106.25, 105.96, 102.90, LC C 25 H 19 O 6 {[M+H] + }calculated 415.17, actual 415.10.
实施例13Example 13
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2m)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3m。Add chrysin (compound represented by structural formula (1)) (1mmol, 1eq), cinnamic acid (compound represented by structural formula (2m)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain compound 3m.
所得化合物3m:黄色固体,收率74.4%,m.p.172.3~174.5℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.14(d,J=7.2Hz,2H),7.85(d,J=15.9Hz,1H),7.70~7.57(m,3H),7.48(d,J=2.1Hz,1H),7.37(dd,J=8.4,2.0Hz,1H),7.21(d,J=2.1Hz,1H),7.19(s,1H),7.03(d,J=8.4Hz,1H),6.85(d,J=16.0Hz,1H),6.76(d,J=2.0Hz,1H),3.83(d,J=6.6Hz,6H);13C NMR(125MHz,DMSO-d6)δ:183.14,164.93,164.67,161.26,156.83,156.56,152.03,149.49,148.18,132.93,130.87,129.70,127.15,127.03,124.35,114.29,111.95,111.00,108.71,106.23,105.92,102.24,56.13,56.08;LC-MS(ESI)m/z:C26H20NaO7{[M+Na]+}计算值467.11,实际值467.10。The obtained compound 3m: yellow solid, yield 74.4%, mp172.3~174.5℃; 1 H NMR (500MHz, DMSO-d 6 )δ: 12.88(s, 1H), 8.14(d, J=7.2Hz, 2H) ,7.85(d,J=15.9Hz,1H),7.70~7.57(m,3H),7.48(d,J=2.1Hz,1H),7.37(dd,J=8.4,2.0Hz,1H),7.21( d,J=2.1Hz,1H),7.19(s,1H),7.03(d,J=8.4Hz,1H),6.85(d,J=16.0Hz,1H),6.76(d,J=2.0Hz, 1H), 3.83 (d, J=6.6Hz, 6H); 13 C NMR (125MHz, DMSO-d 6 ) δ: 183.14, 164.93, 164.67, 161.26, 156.83, 156.56, 152.03, 149.49, 148.18, 132.93, 130.87, 129.70, 127.15, 127.03, 124.35, 114.29, 111.95, 111.00, 108.71, 106.23, 105.92, 102.24, 56.13, 56.08; LC-MS (ESI) m/z: C 26 H 20 NaO 7 {[M+Na] + } The calculated value is 467.11, and the actual value is 467.10.
实施例14Example 14
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2n)所示化合物)(1.5mmol,1.5eq.)、EDCI(1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3n。In a 50mL round bottom flask, add chrysin (compound shown in structural formula (1)) (1mmol, 1eq), cinnamic acid (compound shown in structural formula (2n)) (1.5mmol, 1.5eq.), EDCI (1.5mmol , 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N 2 , add dichloromethane (10.0mL), react at room temperature for about 6h (TLC detection), after the reaction is complete, suction filter, filter The cake was washed successively with petroleum ether, ethyl acetate and acetone, and dried to obtain compound 3n.
所得化合物3n:黄色固体,收率90.6%,m.p.220.2~221.4℃;1H NMR(500MHz,DMSO-d6)δ:12.88(s,1H),8.18~8.11(m,2H),7.84(d,J=15.9Hz,1H),7.68~7.57(m,3H),7.55(d,J=1.7Hz,1H),7.32(dd,J=8.2,1.7Hz,1H),7.21(d,J=2.1Hz,1H),7.18(s,1H),7.01(d,J=8.0Hz,1H),6.79(d,J=15.9Hz,1H),6.76(d,J=2.0Hz,1H),6.12(s,2H);13CNMR(125MHz,DMSO-d6)δ:183.14,164.86,164.69,161.26,156.84,156.52,150.45,148.65,147.82,132.94,130.87,129.71,128.68,127.15,126.49,114.71,109.07,108.74,107.39,106.24,105.97,102.27;LC-MS(ESI)m/z:C25H17O7{[M+H]+}计算值429.10,实际值429.10。The obtained compound 3n: yellow solid, yield 90.6%, mp220.2~221.4℃; 1 H NMR (500MHz, DMSO-d 6 )δ: 12.88(s, 1H), 8.18~8.11(m, 2H), 7.84( d, J=15.9Hz, 1H), 7.68~7.57(m, 3H), 7.55(d, J=1.7Hz, 1H), 7.32(dd, J=8.2, 1.7Hz, 1H), 7.21(d, J =2.1Hz,1H),7.18(s,1H),7.01(d,J=8.0Hz,1H),6.79(d,J=15.9Hz,1H),6.76(d,J=2.0Hz,1H), 6.12(s,2H); 13 CNMR(125MHz,DMSO-d 6 )δ:183.14,164.86,164.69,161.26,156.84,156.52,150.45,148.65,147.82,132.94,130.87,129.71,111.415,12 1 , 109.07, 108.74, 107.39, 106.24, 105.97, 102.27; LC-MS (ESI) m/z: Calcd. for C 25 H 17 O 7 {[M+H] + } 429.10, found 429.10.
对比例1Comparative example 1
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)和肉桂酸(结构式(2a)所示化合物)(1.5mmol,1.5eq.),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约6h(TLC检测),发现反应不能进行,不能得到目标产物化合物3a。Chrysin (compound shown in structural formula (1)) (1mmol, 1eq) and cinnamic acid (compound shown in structural formula (2a)) (1.5mmol, 1.5eq.) were added successively in a 50mL round bottom flask, and then in N 2 Under the protection of , dichloromethane (10.0 mL) was added and reacted at room temperature for about 6 h (TLC detection). It was found that the reaction could not proceed, and the
对比例2Comparative example 2
在50mL的圆底烧瓶中依次加入白杨素(结构式(1)所示化合物)(1mmol,1eq)、肉桂酸(结构式(2a)所示化合物)(1.5mmol,1.5eq.)、DCC(N,N'-二环己基碳酰亚胺,1.5mmol,1.5eq)和DMAP(0.5mmol,0.5eq),然后在N2的保护下,加入二氯甲烷(10.0mL),常温下反应约8h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3a,产率为84.6%,但所得化合物3a仍含有杂质。Chrysin (compound represented by structural formula (1)) (1mmol, 1eq), cinnamic acid (compound represented by structural formula (2a)) (1.5mmol, 1.5eq.), DCC (N, N'-dicyclohexylcarboimide, 1.5mmol, 1.5eq) and DMAP (0.5mmol, 0.5eq), then under the protection of N2 , dichloromethane (10.0mL) was added, and the reaction was carried out at room temperature for about 8h ( TLC detection), after the reaction was completed, suction filtration, the filter cake was washed with petroleum ether, ethyl acetate, acetone successively, and dried to obtain
对比例3Comparative example 3
在50mL的圆底烧瓶中依次加入二氯甲烷(10.0mL)、肉桂酸(结构式(2a)所示化合物)(1.5mmol,1.5eq.)和氯化亚砜(1.5mmol,1.5eq.),室温下反应约8小时,浓缩除去溶剂后再次溶于二氯甲烷(10.0mL),在体系中加入白杨素(结构式(1)所示化合物)(1mmol,1eq),常温下反应约8h(TLC检测),反应完毕后,抽滤,将滤饼依次使用石油醚、乙酸乙酯、丙酮洗涤后,干燥,即得化合物3a,产率为86.5%。Add dichloromethane (10.0mL), cinnamic acid (compound represented by structural formula (2a)) (1.5mmol, 1.5eq.) and thionyl chloride (1.5mmol, 1.5eq.) in sequence in a 50mL round bottom flask, React at room temperature for about 8 hours, concentrate to remove the solvent, and then dissolve in dichloromethane (10.0mL), add chrysin (compound represented by structural formula (1)) (1mmol, 1eq) to the system, and react at room temperature for about 8h (TLC detection), after the reaction was completed, suction filtration was performed, and the filter cake was washed with petroleum ether, ethyl acetate, and acetone in sequence, and then dried to obtain
将实施例1和对比例1-3对比可知,当不加入其他催化剂试剂时,反应不能进行;在EDCI和DMAP的作用下,6h内可反应完全,产率达到95.1%,且所得产物经石油醚、乙酸乙酯、丙酮依次洗涤,即可达到纯净;在DCC和DMAP的作用下,反应时间较长,产率明显降低,且所得产物提纯难度较大;使用SOCl2将肉桂酸酰化后再与白杨素酯化,所需反应时间较少,但需要两步反应,产率略低,且反应条件比较苛刻,因此选择使用EDCI和DMAP的条件来进行该反应最为适宜。Comparing Example 1 and Comparative Example 1-3, it can be seen that when no other catalyst reagents are added, the reaction cannot be carried out; under the action of EDCI and DMAP, the reaction can be completed within 6h, and the yield reaches 95.1%, and the resulting product is purified by petroleum Ether, ethyl acetate, and acetone are washed in sequence to achieve purity; under the action of DCC and DMAP, the reaction time is longer, the yield is significantly reduced, and the resulting product is more difficult to purify; use SOCl2 to acylate cinnamic acid Esterification with chrysin requires less reaction time, but two-step reaction is required, the yield is slightly lower, and the reaction conditions are relatively harsh, so it is most appropriate to choose the conditions of EDCI and DMAP to carry out the reaction.
在实验结果和文献报道基础上[16-18],发明人推测了可能的反应机理(见图2),首先肉桂酸与EDCI反应,生成活性更强的O-酰基异脲,接着白杨素C-7位的羟基进攻O-酰基异脲,生成了相对应的酯与EDCI副产物。同时为了防止在该反应中的O-酰基异脲发生1,3-重排,因此加入酰基转移试剂DMAP以减少副产物的生成。On the basis of experimental results and literature reports [16-18] , the inventor speculated on the possible reaction mechanism (see Figure 2). First, cinnamic acid reacted with EDCI to generate more active O-acylisourea, and then chrysin C The hydroxyl group at the -7 position attacks the O-acylisourea to generate the corresponding ester and EDCI by-products. At the same time, in order to prevent the 1,3-rearrangement of O-acylisourea in this reaction, the acyl transfer reagent DMAP was added to reduce the formation of by-products.
最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that The technical solution of the present invention can be modified or equivalently replaced without departing from the spirit and scope of the technical solution of the present invention.
参考文献references
[1]MOHR J T,KROUT M R,STOLTZ B M.Natural products as inspiration forthe development of asymmetric catalysis[J].Nature,2008,455(7211):323-332.[1] MOHR J T, KROUT M R, STOLTZ B M. Natural products as inspiration for the development of asymmetric catalysis [J]. Nature, 2008, 455(7211): 323-332.
[2]MAYER S,KEGLEVICH P,-BALOGH P,et al.Synthesis and InVitro Anticancer Evaluation of Novel Chrysin and 7-Aminochrysin Derivatives[J].Molecules,2020,25(4):888.[2] MAYER S, KEGLEVICH P, -BALOGH P,et al.Synthesis and InVitro Anticancer Evaluation of Novel Chrysin and 7-Aminochrysin Derivatives[J].Molecules,2020,25(4):888.
[3]DHAWAN K,KUMAR S,SHARMA A.Beneficial effects of chrysin andbenzoflavone on virility in 2-year-old male rats[J].Journal of MedicinalFood,2002,5(1):43-48.[3] DHAWAN K, KUMAR S, SHARMA A.Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats[J].Journal of Medicinal Food,2002,5(1):43-48.
[4]KIM D C,RHO S H,SHIN J C,et al.Inhibition of melanogenesis by 5,7-dihydroxyflavone(chrysin)via blocking adenylyl cyclase activity[J].Biochemical and biophysical research communications,2011,411(1):121-125.[4]KIM D C, RHO S H, SHIN J C, et al.Inhibition of melanogenesis by 5,7-dihydroxyflavone(chrysin)via blocking adenylyl cyclase activity[J].Biochemical and biophysical research communications,2011,411(1):121 -125.
[5]KAMAL A,MURTY J,VISWANATH A,et al.Synthesis,biological evaluationof 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone,5-carboethoxymethyl-4′,7-dihydroxyflavone and their analogues[J].Bioorganic&medicinal chemistryletters,2012,22(14):4891-4895.[5] KAMAL A, MURTY J, VISWANATH A, et al.Synthesis, biological evaluation of 5-carbomethoxymethyl-7-hydroxy-2-pentylchromone, 5-carboethoxymethyl-4′, 7-dihydroxyflavone and their analogues[J].Bioorganic&medicinal chemistry letters ,2012,22(14):4891-4895.
[6]MANI R,NATESAN V.Chrysin:Sources,beneficial pharmacologicalactivities,and molecular mechanism of action[J].Phytochemistry,2018,145:187-196.[6] MANI R, NATESAN V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action [J]. Phytochemistry, 2018, 145: 187-196.
[7]TSUJI P A,WINN R N,WALLE T.Accumulation and metabolism of theanticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analogchrysin in the Atlantic killifish[J].Chemico-biological interactions,2006,164(1-2):85-92.[7]TSUJI P A,WINN R N,WALLE T.Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analogchrysin in the Atlantic killifish[J].Chemico-biological interactions,2006,164(1-2): 85-92.
[8]KASALA E R,BODDULURU L N,MADANA R M,et al.Chemopreventive andtherapeutic potential of chrysin in cancer:mechanistic perspectives[J].Toxicology letters,2015,233(2):214-225.[8] KASALA E R, BODDULURU L N, MADANA R M, et al. Chemopreventive and therapeutic potential of chrysin in cancer: mechanical perspectives [J]. Toxicology letters, 2015, 233(2): 214-225.
[9]屈勇,张怡,熊腾,等.白杨素制剂的研究进展[J].中国药师,2018,21(4):714-717.(QU Y,ZHANG Y,XIONG T,et al.Research progress in the preparations ofchrysin[J].China Pharmacist,2018,21(4):714-717.)[9] Qu Yong, Zhang Yi, Xiong Teng, et al. Research progress of chrysin preparations [J]. Chinese Pharmacist, 2018, 21(4): 714-717. (QU Y, ZHANG Y, XIONG T, et al .Research progress in the preparations ofchrysin[J].China Pharmacist,2018,21(4):714-717.)
[10]褚朝森,王晓丽,胡玉涛,等.一种肉桂酸及其衍生物合成新方法研究[J]应用化工,2015,44(03):442-444+449.[10] Chu Chaosen, Wang Xiaoli, Hu Yutao, et al. Research on a new synthesis method of cinnamic acid and its derivatives [J] Applied Chemical Industry, 2015, 44(03): 442-444+449.
(CHU C S,WANG X L,HU Y T,et al.Research on a new method for thesynthesis of cinnamic acid and its derivatives[J].Applied Chemical Industry,2015,44(03):442-444+449.)(CHU C S, WANG X L, HU Y T, et al. Research on a new method for the synthesis of cinnamic acid and its derivatives[J]. Applied Chemical Industry, 2015, 44(03): 442-444+449.)
[11]WEI Q Y,JIANG H,ZHANG J X,et al.Synthesis of N-hydroxycinnamoylamino acid ester analogues and their free radical scavenging andantioxidative activities[J].Medicinal Chemistry Research,2012,21(8):1905-1911.[11]WEI Q Y, JIANG H, ZHANG J X, et al.Synthesis of N-hydroxycinnamoylamino acid ester analogues and their free radical scavenging and antioxidative activities[J].Medicinal Chemistry Research,2012,21(8):1905-1911.
[12]DENG X Q,WU D,WEI C X,et al.Synthesis and antidepressant-likeaction of N-(2-hydroxyethyl)cinnamamide derivatives in mice[J].MedicinalChemistry Research,2011,20(8):1273-1279.[12]DENG X Q,WU D,WEI C X,et al.Synthesis and antidepressant-likeaction of N-(2-hydroxyethyl)cinnamamide derivatives in mice[J].Medicinal Chemistry Research,2011,20(8):1273-1279.
[13]KUJUR A,KIRAN S,DUBEY N K,et al.Microencapsulation of Gaultheriaprocumbens essential oil using chitosan-cinnamic acid microgel:Improvement ofantimicrobial activity,stability and mode of action[J].LWT,2017,86:132-138.[13] KUJUR A, KIRAN S, DUBEY N K, et al.Microencapsulation of Gaultheria procumbens essential oil using chitosan-cinnamic acid microgel: Improvement of antimicrobial activity, stability and mode of action[J].LWT,2017,86:132-138.
[14]GARCIA-JIMENEZ A,-MOLINA F,TERUEL-PUCHE J A,etal.Catalysis and inhibition of tyrosinase in the presence of cinnamic acidand some of its derivatives[J].International journal of biologicalmacromolecules,2018,119:548-554.[14]GARCIA-JIMENEZ A, -MOLINA F, TERUEL-PUCHE JA, etal.Catalysis and inhibition of tyrosinase in the presence of cinnamic acid and some of its derivatives[J].International journal of biological macromolecules,2018,119:548-554.
[15]蒋卫华,孟启.肉桂酸及其衍生物的应用与开发[J].香料香精化妆品,2012,10(5):53-54.[15] Jiang Weihua, Meng Qi. Application and Development of Cinnamic Acid and Its Derivatives[J]. Fragrance, Fragrance and Cosmetics, 2012,10(5):53-54.
(JIANG W H,MENG Q.Application and Development on Cinnamic Acid andits Derivatives[J].Flavour Fragrance Cosmetics,2012,10(5):53-54.)(JIANG W H, MENG Q.Application and Development on Cinnamic Acid and its Derivatives[J].Flavour Fragrance Cosmetics,2012,10(5):53-54.)
[16]BABU S A.EDC/DMAP-mediated direct condensation of dicarboxylicacids and diols:A concise synthesis of extra large polyether macrocycliclactones and their X-ray structures[J].Tetrahedron Letters,2016,57(51):5801-5807.[16]BABU S A.EDC/DMAP-mediated direct condensation of dicarboxylic acids and diols: A compact synthesis of extra large polyether macrocycliclactones and their X-ray structures[J].Tetrahedron Letters,2016,57(51):5801-5807 .
[17]MCCOURT R O,SCANLAN E M.A Sequential Acyl Thiol–Ene andThiolactonization Approach for the Synthesis ofδ-Thiolactones[J].Organicletters,2019,21(9):3460-3464.[17]MCCOURT R O,SCANLAN E M.A Sequential Acyl Thiol–Ene and Thiolactonization Approach for the Synthesis ofδ-Thiolactones[J].Organicletters,2019,21(9):3460-3464.
[18]蔡冉,王浦海,孙立,等.EDCI/DMAP存在下7-乙基喜树碱与乙酰水杨酸的反应[J].化学研究与应用,2016,28(02),214-217.[18] Cai Ran, Wang Puhai, Sun Li, et al. Reaction of 7-ethylcamptothecin and acetylsalicylic acid in the presence of EDCI/DMAP[J]. Chemical Research and Application, 2016, 28(02), 214- 217.
(CAI R,WANG P H,SUN L.Studies on esterification reaction of 7-ethylcamptothecin and acetylsalicylic acid in presence of EDCI/DMAP[J].Chemical Research and Application,2016,28(02),214-217)(CAI R, WANG P H, SUN L.Studies on esterification reaction of 7-ethylcamptothecin and acetylsalicylic acid in presence of EDCI/DMAP[J].Chemical Research and Application,2016,28(02),214-217)
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010891873.1A CN111995605B (en) | 2020-08-28 | 2020-08-28 | Chrysin cinnamate or its derivative and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010891873.1A CN111995605B (en) | 2020-08-28 | 2020-08-28 | Chrysin cinnamate or its derivative and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111995605A CN111995605A (en) | 2020-11-27 |
CN111995605B true CN111995605B (en) | 2023-02-17 |
Family
ID=73464740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010891873.1A Active CN111995605B (en) | 2020-08-28 | 2020-08-28 | Chrysin cinnamate or its derivative and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111995605B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114874124B (en) * | 2022-05-12 | 2023-07-04 | 五邑大学 | Melatonin cinnamic acid derivative and preparation method thereof |
-
2020
- 2020-08-28 CN CN202010891873.1A patent/CN111995605B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111995605A (en) | 2020-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0129091B1 (en) | Thiochroman esters of phenois and tere-pnthallates having retinoid-lihe activity | |
CA2498248A1 (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
EP2468741A1 (en) | Novel quercetin derivatives, their preparation, pharmaceutical compositions containing them and their use | |
CN111995605B (en) | Chrysin cinnamate or its derivative and its preparation method | |
CN113666824A (en) | A kind of cannabidiol-2-propionate and application thereof | |
CN105218621A (en) | One class dehydroabietic acid Benzimidazole Schiff base class Hete rocyclic derivatives with anti-tumor activity and its preparation method and application | |
CN113735709A (en) | Cannabidiol-2-butyrate and application thereof | |
KR100346672B1 (en) | Method for preparing 3-O-substituted ascorbic acid | |
CN106220600A (en) | Flavone derivatives and its production and use | |
CN103145636B (en) | 1,4-diacyl-3,6-diphenyl-1,4-dihydrotetrazine compound as well as preparation method and application thereof | |
CN110845466A (en) | Oxacyclononadiene derivative, pharmaceutical composition thereof, preparation method and application thereof | |
Whitlock et al. | Passage of aryl-tipped alkyl groups through molecular cavities: the role of flexibility | |
JPH01305078A (en) | Novel heteroarotinoide derivative | |
CN112374976B (en) | Novel method for synthesizing curcumin analogue | |
CN104003968A (en) | Natural product 3-prenyl Iuteolin analogue (I)/(II), preparation method of natural product 3-prenyl Iuteolin analogue (I)/(II), and application of natural product 3-prenyl Iuteolin analogue (I)/(II) | |
CN105732547B (en) | A kind of preparation method of Dehydro and drographolide diacid half esters | |
CN102516066B (en) | Ostopanic acid analog and Preparation method and use | |
JP6082644B2 (en) | Process for producing danidazole constituent optical isomers | |
CN106038560A (en) | Application of sulfur-containing andrographolide derivatives in preparing medicines for treating prostatic cancer | |
CN103755585A (en) | Derivatives of ent-kaurenoid compounds, and preparation method and application thereof | |
CN115093315B (en) | A method for synthesizing 2-benzylidene-3-cyclohexenone compound | |
JPS5830289B2 (en) | Synquiterpenophenol | |
CN113896616A (en) | A kind of preparation method of cannabidiol | |
CN112094257B (en) | Preparation method of delta-9 tetrahydrocannabinol | |
CN112552258B (en) | Thiazole amidoisomagnolanine derivatives, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |